Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Biography

Judith Bliss is Professor of Clinical Trials at The Institute of Cancer Research, London, Director of its Cancer Research UK funded Clinical Trials & Statistics Unit (ICR-CTSU) and an NIHR Senior Investigator.

A trials statistician with over 30 years’ experience, her professional interests are in the design and analysis of cancer clinical trials; driven by a desire that trials are efficient and sufficiently robust to provide the safety and efficacy results required to directly influence routine clinical practice internationally. She has been a long standing member of the UK NCRI Breast CSG and is Chair of the UK Breast Intergroup and of the NCRI Cancer CTU Group.

Focus for contemporary trial activity is on establishing evidence for biologically targeted therapies utilising biologically-defined intermediate endpoints to drive therapeutic choices and predict outcomes. She collaborates with key clinical and scientific opinion leaders and pharmaceutical company partners as required. She is working with NCRAS to overcome the challenges of integrating routinely collected data in ongoing trials.

Forthcoming events

Title TBC

Monday, 15 April 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

The effects of BCG on non-specific resistance to respiratory infection

Monday, 13 May 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Title TBC

Monday, 20 May 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms